Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have signed a specific type of informed consent form required for this study.
- People who are able to follow the study procedures, as assessed by the study investigator.
- People who are 18 years of age or older.
- People who have a confirmed diagnosis of multiple sclerosis (any type: relapsing-remitting, secondary progressive, or primary progressive MS) based on the 2017 McDonald diagnostic criteria.
- People who are willing and able to install and use two apps — MS Sherpa and NeuroKeys — on their own personal mobile phone.
- People who are currently taking part in another clinical trial involving a treatment or intervention are still able to participate in this study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- There are no specific exclusion criteria listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joep Killestein, Prof, Amsterdam UMC
Phone: +31625716307
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Impact of digital monitoring questionnaire: healthcare provider; Adherence to the MS Sherpa application.; Application outcomes of MS Sherpa; Impact of digital monitoring questionnaire: patient; Adherence to the Neurokeys application; Medical consumption questionnaire (iMCQ); Productivity costs questionnaire (iPCQ); Application outcomes of Neurokeys
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.